Computer-based Evolutionary Search for a Nonlinear Conversion Function for Establishing In Vitro-In Vivo Correlation (IVIVC) of Oral Drug Formulations

被引:12
|
作者
Yamashita, Fumiyoshi [1 ]
Fujita, Atsuto
Zhang, Xingyi
Sasa, Yukako
Mihara, Kiyoshi [3 ]
Hashida, Mitsuru [2 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan
[3] Musashino Univ, Res Ctr Clin Pharm, Fac Pharm, Nishitokyo, Japan
基金
日本学术振兴会;
关键词
in vitro-in vivo correlation; genetic expression programming; genetic algorithm; nonlinear optimization; diltiazem; sustained release; EXTENDED-RELEASE FORMULATION; DOSAGE FORM; DILTIAZEM; PHARMACOKINETICS; ABSORPTION;
D O I
10.2133/dmpk.DMPK-11-RG-075
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Establishment of in vitro in vivo correlation (IVIVC) accelerates optimization of desirable drug formulations and/or modification of the manufacturing processes in the scale-up and post-approval periods. This article presents a method of finding the optimal conversion function for establishing Level A point-to-point IVIVC, based on a computer-based evolutionary search technique. Gene expression programming (GEP) is a technique for optimizing a mathematical expression tree with the help of a genetic algorithm. A parameter optimization routine, which minimizes the number of parameters in the mathematical expression trees and estimates the best-fit parameter values, was implemented in the GEP algorithm. Feasibility of the computer program was investigated using the in vitro and in vivo data for sustained release diltiazem formulations. It provided a mathematical equation that, from their in vitro dissolution profiles, successfully predicts the plasma concentration profiles of three different formulations of diltiazem following oral administration. Because the present approach does not use intravenous injection data like conventional IVIVC analyses, it is widely applicable to the evaluation of various oral formulations.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 35 条
  • [21] In vitro-in vivo-in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug
    Changzhi Shi
    Jelisaveta Ignjatovi?
    Tingting Liu
    Meihua Han
    Dongmei Cun
    Jelena ?uri?
    Mingshi Yang
    Sandra Cviji?
    AsianJournalofPharmaceuticalSciences, 2021, 16 (03) : 350 - 362
  • [22] In vitro-in vivo correlation for the microsphere and in situ implant-based control led-release depot injectable formulations
    Nahata, T.
    Saini, T. R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A33 - A34
  • [23] Design, evaluation, and in vitro-in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide
    Venkatasubramanian, Ramakrishnan
    Al-Maghrabi, Passant M.
    Alavi, Oscar
    Lind, Tania
    Sassene, Philip Jonas
    Kirkensgaard, Jacob J. K.
    Mota-Santiago, Pablo
    Rades, Thomas
    Mullertz, Anette
    JOURNAL OF CONTROLLED RELEASE, 2025, 379 : 440 - 451
  • [24] In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior
    Kataoka, Makoto
    Minami, Keiko
    Takagi, Toshihide
    Amidon, Gregory E.
    Yamashita, Shinji
    MOLECULAR PHARMACEUTICS, 2021, 18 (11) : 4122 - 4130
  • [25] Development of In Vitro-In Vivo Correlation for Extended-Release Niacin After Administration of Hypromellose-Based Matrix Formulations to Healthy Volunteers
    Kesisoglou, Filippos
    Rossenu, Stefaan
    Farrell, Colm
    Van Den Heuvel, Michiel
    Prohn, Marita
    Fitzpatrick, Shaun
    De Kam, Pieter-Jan
    Vargo, Ryan
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (11) : 3713 - 3723
  • [26] A single dose five-way cross-over study to establish an in vitro/in vivo correlation (IVIVC) for oral extended release (ER) formulations with 0.375 mg pramipexole
    Haertter, S.
    Koenen-Bergmann, M.
    Narjes, H.
    Gerken, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 96 - 96
  • [27] A single dose five-way cross-over study to establish an in vitro/in vivo correlation (IVIVC) for oral extended release (ER) formulations with 0.375 mg pramipexole
    Haertter, S.
    Koenen-Bergmann, M.
    Narjes, H.
    Gerken, F.
    Rascol, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 74 - 74
  • [28] Assessment of in Vivo Performance of Lipid-Based Formulations: Correlation between in Vitro Drug Release Profiles and in Vivo Absorption Rate Profiles
    Higashino, Haruki
    Masada, Takato
    Minami, Keiko
    Kataoka, Makoto
    Yamashita, Shinji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (10) : 1616 - 1623
  • [29] Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation
    Sirvi, Arvind
    Jadhav, Karan
    Sangamwar, Abhay T.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 656
  • [30] Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug
    Li, Ziqiang
    He, Xin
    Tian, Shuang
    Feng, Guo
    Huang, Cong
    Xun, Mingjin
    Wu, Zengguang
    Wang, Yangyang
    AAPS PHARMSCITECH, 2019, 20 (08)